ArticleStem cell research & therapy2025
MicroRNA-4516 in extracellular vesicles-derived mesenchymal stem cells suppressed integrin αV-mediated lung fibrosis.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Interception of Regulatory RNAs on TGF-β Signaling in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Systematic Review.Current allergy and asthma reports · 2026Pooled it
- How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies.Molecular biology reports · 2026Review
- Urinary Extracellular Vesicle-Derived miRNAs Reveal a Coordinated Stress-Response Network Linked to Advanced Glycation End-Products in Children and Adolescents.Antioxidants (Basel, Switzerland) · 2026Article
- Article
- MSC-EVs attenuate subretinal fibrosis in choroidal neovascularization through miR-21-5p-mediated inhibition of EMT and MMT and suppression of inflammation.Journal of neuroinflammation · 2026Article
- Therapeutic microRNAs: Mechanisms, Delivery, and Clinical Translation in Oncology.International journal of molecular sciences · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundIdiopathic pulmonary fibrosis (IPF) is characterized by the recruitment of lung fibroblasts to sites within the lung interstitium, along with the differentiation of myofibroblasts induced by transforming growth factor (TGF)-β1, a mediator of fibrosis, which, in turn, leads to accelerated contractile lung fibrotic processes with excessive extracellular matrix (ECM) deposition. Extracellular vesicles (EVs) are small particles released by cells that contain physiologically active substances, including messenger RNAs, microRNAs (miRNAs), and proteins. Although EVs derived from mesenchymal stem cells (MSCs) are expected to be a promising drug for various intractable diseases, including IPF, the underlying mechanisms remain elusive. In this study, we aimed to elucidate the mechanisms underlying the effect of MSC-EVs on lung fibroblast-mediated antifibrotic processes.
methodsThe ability of TGF-β1-stimulated lung fibroblasts to migrate toward fibronectin and to contract three-dimensional type I collagen gels was evaluated. Using a miRNA array, we aimed to identify miRNAs associated with fibrotic mechanisms in MSC-EVs. Furthermore, the effects of MSC-EVs were analyzed in a mouse model of bleomycin (BLM)-induced lung fibrosis, including the resulting histopathology, degree of fibrosis, and downstream signaling pathways.
resultsAdministration of MSC-EVs resulted in significant suppression of TGF-β1-stimulated collagen gel contraction, migration, and expression of α-smooth muscle actin and ECM. Upon treatment with MSC-EVs, lung fibroblasts derived from fibrotic lungs showed greater inhibition of responses than normal lung fibroblasts. These effects were mediated via the integrin αV-mediated focal adhesion kinase signaling through the MAPK pathway, including JNK, p38MAPK, and/or ERK1/2 signaling. miR-4516, identified in MSC-EVs in human lung fibroblasts, recapitulated these effects. Administration of MSC-EVs resulted in the significant accumulation and attenuation of BLM-induced fibrotic lung tissue, along with the reduced expression of integrin αV in the lung interstitium.
conclusionCollectively, the findings of this study indicate that MSC-EVs may represent a promising novel therapeutic strategy to address the pulmonary fibroblast-mediated mechanisms of lung fibrosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.